Professional Development Time Sample Clauses

Professional Development Time. The following Section 2 is contingent on full levy funding. The District will provide and direct the equivalent of two (2) professional development days during the course of each contract year. Payment for professional development time covered by this section is available to staff that attend and participate in professional development activities and document their participation on a building attendance roster. Leave, such as sick, emergency, personal, bereavement, etc., will not be permitted.
Sample 1Sample 2
AutoNDA by SimpleDocs
Professional Development Time. Executive shall be entitled to a period of fifteen (15) days per year (accrued fully at the beginning of each calendar year) of Professional Development Time to attend conventions or continuing education seminars or any other reason approved by the Board, in its reasonable discretion. There shall be a carryover of such time from year to year. However, no compensation shall be paid to Executive for any unused Professional Development Time upon termination of this Agreement.
Sample 1Sample 2
Professional Development Time. To support the standard employment contract expectation to grow professionally, staff members will participate in individual and collegial activities such as self- reflection, goal setting, workshops, classes, conferences or other collaborative meetings to support student learning. In order to make effective use of the available student release time within the standard contract, including but not limited to early release days, the time will be allocated as follows:  50 percent self-directed  50 percent District-directed The schedule of this time shall be determined through a building-level decision making process.
Sample 1Sample 2
Professional Development Time. To assist teachers in continually improving the instructional program, professional development will include frequent and regular periods designed to provide continuing teacher support, opportunities for teacher collaboration and joint planning, and assessment of the impact of innovations on student achievement. These opportunities will be scheduled during the school day without decreasing students’ instructional time. Additional teacher in-service half days or full days may be scheduled as needed.
Sample 1
Professional Development Time. At the discretion of the appropriate Director, Professional Librarians and Professional Counsellors will be given a maximum of ten working days of time off for approved professional development activities.
Sample 1
Professional Development Time. A teacher planning to use professional development time shall confer with and obtain approval from his/her principal at least one (1) week in advance of his/her absence. The teacher shall leave complete plans and adequate materials for substitute use. The Board shall provide for a substitute teacher and reimburse for agreed upon fees, housing, mileage and meals. When possible, members of staff who share responsibilities will attend the same conference to consolidate expenses.
Sample 1
Professional Development Time. Professional development activities include personal growth, professional and career development activities which may reasonably be construed as work related.
Sample 1
AutoNDA by SimpleDocs
Professional Development Time. The parties reaffirm the substantive terms of Paragraph 11/5/1 on the basis of the arbitration award issued by Arbitrator Xxxxxxx and dated August 5, 1998. Bargaining unit members have five (5) days of “professional development” time off during each calendar year. Such time does not have some of the attributes of “vacation,” i.e., it cannot be carried over from year to year, but it does not have to be work related. It is additional time off to be used for fulfillment of “personal professional needs.” The Employer may only deny a request for such available leave for operational reasons. Employees may use such days at their individual discretion for the employee’s professional needs or to satisfy any other unrestricted personal professional needs as deemed appropriate by the employee. The Employer is obligated to grant the leave whenever operations permit and is not entitled to information as to the specific reason(s) for use of the leave. If the Employer approves the leave, but then has reason to believe that the employee has abused this provision, the Employer is then free to investigate the matter and, if appropriate, take disciplinary action for just cause, as it could do in the case of abuse of other types of leave. MEMORANDUM OF UNDERSTANDING 1 The current Uniform Travel Schedule Amounts (UTSAs) are defined in Section F of the Compensation Plan, which is posted on the Office of State Employment Relations website. MEMORANDUM OF UNDERSTANDING 2
Sample 1
Professional Development Time 
Sample 1Sample 2

Related to Professional Development Time

  • Clinical Development Licensee will have sole responsibility for and sole decision making over the clinical development of any Product arising from the Research Program in the Field. Notwithstanding the foregoing, if Licensee wishes to conduct clinical development of a Development Candidate at Penn and Penn has the clinical expertise, interest and ability to run such a trial as assessed at Penn’s sole discretion, such a study will be conducted under a separate Clinical Trial Agreement to be negotiated by the Parties prior to initiation of such study. Such separate clinical trial agreement will include a detailed clinical development plan, including costs and time lines for conducting the Clinical Trial.

  • Initial Development Plan Not later than the Effective Date, Licensee shall have provided Merck with an initial Development plan for the Licensed Product in the Field in the Territory, which shall be incorporated as part of this Agreement as Attachment 3.02(a) (as may be amended in accordance with this Agreement, the “Development Plan”). **CERTAIN INFORMATION IN THIS EXHIBIT HAS BEEN OMITTED AND WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT REQUEST.

  • Business Development Company Buyer is a business development company as defined in Section 202(a)(22) of the Investment Advisors Act of 1940.

  • Joint Development If joint development is involved, the Recipient agrees to follow the latest edition of FTA Circular 7050.1, “Federal Transit Administration Guidance on Joint Development.”

  • Research Independence The Company acknowledges that each Underwriter’s research analysts and research departments, if any, are required to be independent from their respective investment banking divisions and are subject to certain regulations and internal policies, and that such Underwriter’s research analysts may hold and make statements or investment recommendations and/or publish research reports with respect to the Company and/or the offering that differ from the views of its investment bankers. The Company hereby waives and releases, to the fullest extent permitted by law, any claims that the Company may have against such Underwriter with respect to any conflict of interest that may arise from the fact that the views expressed by their independent research analysts and research departments may be different from or inconsistent with the views or advice communicated to the Company by such Underwriter’s investment banking divisions. The Company acknowledges that the Representative is a full service securities firm and as such from time to time, subject to applicable securities laws, may effect transactions for its own account or the account of its customers and hold long or short position in debt or equity securities of the Company.

  • Collaboration Management Promptly after the Effective Date, each Party will appoint a person who will oversee day-to-day contact between the Parties for all matters related to the management of the Collaboration Activities in between meetings of the JSC and will have such other responsibilities as the Parties may agree in writing after the Effective Date. One person will be designated by Merck (the “Merck Program Director”) and one person will be designated by Moderna (the “Moderna Program Director,”) together will be the “Program Directors”. Each Party may replace its Program Director at any time by notice in writing to the other Party. Any Program Director may designate a substitute to temporarily perform the functions of that Program Director by written notice to the other Party. The initial Program Directors will be: For Moderna: [***] For Merck: [***]

  • Independent Development Receiving Party may currently or in the future be developing information internally, or receiving information internally, or receiving information from other parties that may be similar to the Disclosing Party's Confidential Information. Accordingly, nothing in this Agreement will be construed as a representation or inference that Receiving Party will not develop or have developed products or services, that, without violation of this Agreement, might compete with the products or systems contemplated by the Disclosing Party's Confidential Information.

  • Medical Director The Contractor shall employ the services of a Medical Director who is a licensed Indiana Health Care Provider (IHCP) provider board certified in family medicine or internal medicine. If the Medical Director is not board certified in family medicine, they shall be supported by a clinical team with experience in pediatrics, behavioral health, adult medicine and obstetrics/gynecology. The Medical Director shall be dedicated full-time to the Contractor’s Indiana Medicaid product lines. The Medical Director shall oversee the development and implementation of the Contractor’s disease management, case management and care management programs; oversee the development of the Contractor’s clinical practice guidelines; review any potential quality of care problems; oversee the Contractor’s clinical management program and programs that address special needs populations; oversee health screenings; serve as the Contractor’s medical professional interface with the Contractor’s primary medical providers (PMPs) and specialty providers; and direct the Quality Management and Utilization Management programs, including, but not limited to, monitoring, corrective actions and other quality management, utilization management or program integrity activities. The Medical Director, in close coordination with other key staff, is responsible for ensuring that the medical management and quality management components of the Contractor’s operations are in compliance with the terms of the Contract. The Medical Director shall work closely with the Pharmacy Director to ensure compliance with pharmacy-related responsibilities set forth in Section 3.4. The Medical Director shall attend all OMPP quality meetings, including the Quality Strategy Committee meetings. If the Medical Director is unable to attend an OMPP quality meeting, the Medical Director shall designate a representative to take his or her place. Notwithstanding the Medical Director ‘s sending of a representative, the Medical Director shall be responsible for knowing and taking appropriate action on all agenda and action items from all OMPP quality meetings.

  • Business Development Company Status The Company, during a period of at least 12 months from the Closing Time, will use its commercially reasonable efforts to maintain its status as a business development company; provided, however, the Company may cease to be, or withdraw its election as, a business development company, with the approval of the board of directors and a vote of stockholders as required by Section 58 of the 1940 Act or any successor provision.

  • Business Development Provide advice and assistance in business growth and development of Party B. 业务发展。对乙方的业务发展提供建议和协助。

Time is Money Join Law Insider Premium to draft better contracts faster.